This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Galena CEO Fired Following Stock-Promotions Scandal

Updated from 6:07 am EDT with additional Galena comment.

Lake Oswego, Oreg. (TheStreet) -- Galena Biopharma (GALE - Get Report) CEO Mark Ahn was fired by the board of directors at a special meeting held Monday, according to a source close to the company.

Ahn's forced exit from the troubled Galena follows an internal investigation by the board which scrutinized the company's hiring of an investor relations firm to engage in a stock-promotions campaign. This investor relations firm, The DreamTeam Group, used false names to write and publish misleading and promotional articles about Galena on DIY investor web sites like Seeking Alpha.

After Galena's stock price rose due to the promotional campaign, Ahn and other insiders made millions of dollars by selling company stock.

Read MoreBiotech Stock Mailbag: Exact Sciences, Galena, Amgen

The Securities and Exchange Commission is also investigating Galena's role in the stock promotions scheme.

Galena tried to soften the blow of Ahn's firing in an announcement Thursday, claiming he resigned "to pursue other long held personal and professional goals." Galena Chief Operating Officer Mark Schwartz was named CEO to replace Ahn.

Last February, Ahn responded to my reporting on the DreamTeam stock promotion scandal by issuing a letter to shareholders in which he accused me of having an "agenda when it comes to Galena" and said my reporting on the company was "tabloid-like" and "largely devoid of true information."

But less than a month later, Galena disclosed that the SEC was investigating the matter, and the company's board began its own, internal inquiry into the hiring of the DreamTeam investor relations firm. That internal investigation was completed in July, the company disclosed recently, but without detailing conclusions reached or what corrective steps were taken.

In addition to the SEC investigation, five lawsuits have been filed against Galena in federal and state court, accusing the company of violating federal securities laws and breaching fiduciary duties. All the lawsuits pertain to Galena's involvement in the stock-promotion campaign and the insider stock sales.

Galena's stock price has been cut in half since the DreamTeam story was published. Shares closed Wednesday night at $2.32.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
GALE $1.35 0.00%
AAPL $123.25 0.00%
FB $83.30 0.00%
GOOG $548.34 0.00%
TSLA $185.00 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs